The Role of MicroRNA-381 in Chondrogenesis and Interleukin-1-β Induced Chondrocyte Responses

Cellular Physiology and Biochemistry

Volumn 36, Issue 5, 2015, Pages 1753-1766

  Hou, Changhe ^a   Meng, Fangang ^a   Zhang, Zhiqi ^a   Kang, Yan ^a   Chen, Weishen ^a   Huang, Guangxin ^a   Fu, Ming ^a   Sheng, Puyi ^a   Zhang, Ziji ^a   Liao, Weiming ^a  

^a THE FIRST AFFILIATED HOSPITAL OF SUN YAT SEN UNIVERSITY   (China)

Author keywords

Cartilage degeneration; Chondrogenesis; Metalloproteinase 13; MIR 381; Osteoarthritis

Indexed keywords

COLLAGEN TYPE 2; COLLAGENASE 3; I KAPPA B KINASE ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; MICRORNA; MICRORNA 381; SMALL INTERFERING RNA; TRANSCRIPTION FACTOR RUNX2; TRANSCRIPTION FACTOR SOX9; UNCLASSIFIED DRUG; MIRN381 MICRORNA, HUMAN; RUNX2 PROTEIN, HUMAN; SOX9 PROTEIN, HUMAN;

ANIMAL CELL; ARTICLE; CARTILAGE CELL; CARTILAGE DEGENERATION; CHONDROGENESIS; EMBRYO; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; LUCIFERASE ASSAY; MOUSE; NONHUMAN; OSTEOARTHRITIS; PLASMID; PRIORITY JOURNAL; PROTEIN EXPRESSION; RNA SYNTHESIS; ANIMAL; ARTHRITIS; CELL LINE; CYTOLOGY; GENETICS; METABOLISM; PATHOLOGY; PHYSIOLOGY;

ANIMALS; ARTHRITIS; CELL LINE; CHONDROCYTES; CHONDROGENESIS; COLLAGEN TYPE II; CORE BINDING FACTOR ALPHA 1 SUBUNIT; HUMANS; INTERLEUKIN-1BETA; MATRIX METALLOPROTEINASE 13; MICE; MICRORNAS; SOX9 TRANSCRIPTION FACTOR;

EID: 84937780659     PISSN: 10158987     EISSN: 14219778     Source Type: Journal    
DOI: 10.1159/000430148     Document Type: Article

References (59)

1. Zhang Y, Jordan JM: Epidemiology of Osteoarthritis. Clin Geriatr Med 2010;26:355-369.
2. Le LT, Swingler TE, Clark IM: Review: The role of microRNAs in osteoarthritis and chondrogenesis. Arthritis Rheum 2013;65:1963-1974.
3. Shlopov BV, Gumanovskaya ML, Hasty KA: Autocrine regulation of collagenase 3 (matrix metalloproteinase 13) during osteoarthritis. Arthritis Rheum 2000;43:195-205.
4. Huebner JL, Otterness IG, Freund EM, Caterson B, Kraus VB: Collagenase 1 and collagenase 3 expression in a Guinea pig model of osteoarthritis. Arthritis Rheum 1998;41:877-890.
5. Stoop R, van der Kraan PM, Buma P, Hollander AP, Billinghurst RC, Poole AR, van den Berg WB: Type II collagen degradation in spontaneous osteoarthritis in C57Bl/6 and BALB/c mice. Arthritis Rheum 1999;42:2381-2389.
6. Stoop R, van der Kraan PM, Buma P, Hollander AP, Poole AR, van den Berg WB: Denaturation of type II collagen in articular cartilage in experimental murine arthritis. Evidence for collagen degradation in both reversible and irreversible cartilage damage. J Pathol 1999;188:329-337.
7. Hollander AP, Heathfield TF, Webber C, Iwata Y, Bourne R, Rorabeck C, Poole AR: Increased damage to type II collagen in osteoarthritic articular cartilage detected by a new immunoassay. J Clin Invest 1994;93:1722-1732.
8. Nishimura R, Wakabayashi M, Hata K, Matsubara T, Honma S, Wakisaka S, Kiyonari H, Shioi G, Yamaguchi A, Tsumaki N, Akiyama H, Yoneda T: Osterix regulates calcification and degradation of chondrogenic matrices through matrix metalloproteinase 13 (MMP13) expression in association with transcription factor Runx2 during endochondral ossification. J Biol Chem 2012;287:33179-33190.
9. Hirata M, Kugimiya F, Fukai A, Saito T, Yano F, Ikeda T, Mabuchi A, Sapkota BR, Akune T, Nishida N, Yoshimura N, Nakagawa T, Tokunaga K, Nakamura K, Chung UI, Kawaguchi H: C/EBPbeta and RUNX2 cooperate to degrade cartilage with MMP-13 as the target and HIF-2alpha as the inducer in chondrocytes. Hum Mol Genet 2012;21:1111-1123.
10. Diederichs S, Zachert K, Raiss P, Richter W: Regulating chondrogenesis of human mesenchymal stromal cells with retinoic acid receptor-beta inhibitor: differential sensitivity of chondral verus osteochondral development. Cell Physiol Biochem 2014;33:1607-1619.
11. Kobayashi T, Lu J, Cobb BS, Rodda SJ, McMahon AP, Schipani E, Merkenschlager M, Kronenberg HM: Dicer-dependent pathways regulate chondrocyte proliferation and differentiation. Proc Natl Acad Sci U S A 2008;105:1949-1954.
12. Dong S, Yang B, Guo H, Kang F: MicroRNAs regulate osteogenesis and chondrogenesis. Biochem Biophys Res Commun 2012;418:587-591.
13. Hong E, Reddi AH: MicroRNAs in chondrogenesis, articular cartilage, and osteoarthritis: implications for tissue engineering. Tissue Eng Part B Rev 2012;18:445-453.
14. Tuddenham L, Wheeler G, Ntounia-Fousara S, Waters J, Hajihosseini MK, Clark I, Dalmay T: The cartilage specific microRNA-140 targets histone deacetylase 4 in mouse cells. FEBS Lett 2006;580:4214-4217.
15. Yang J, Qin S, Yi C, Ma G, Zhu H, Zhou W, Xiong Y, Zhu X, Wang Y, He L, Guo X: MiR-140 is co-expressed with Wwp2-C transcript and activated by Sox9 to target Sp1 in maintaining the chondrocyte proliferation. FEBS Lett 2011;585:2992-2997.
16. Guan YJ, Yang X, Wei L, Chen Q: MiR-365: A mechanosensitive microRNA stimulates chondrocyte differentiation through targeting histone deacetylase 4. FASEB J 2011;25:4457-4466.
17. Barter MJ, Bui C, Young DA: Epigenetic mechanisms in cartilage and osteoarthritis: DNA methylation, histone modifications and microRNAs. Osteoarthritis Cartilage 2012;20:339-349.
18. Park SJ, Cheon EJ, Kim HA: MicroRNA-558 regulates the expression of cyclooxygenase-2 and IL-1beta-induced catabolic effects in human articular chondrocytes. Osteoarthritis Cartilage 2013;21:981-989.
19. Xu J, Kang Y, Liao WM, Yu L: MiR-194 regulates chondrogenic differentiation of human adipose-derived stem cells by targeting Sox5. PLoS One 2012;7:e31861.
20. Zhang Z, Kang Y, Zhang Z, Zhang H, Duan X, Liu J, Li X, Liao W: (2012) Expression of microRNAs during chondrogenesis of human adipose-derived stem cells. Osteoarthritis Cartilage 2012;20:1638-1646.
21. Rothschild SI, Tschan MP, Jaggi R, Fey MF, Gugger M, Gautschi O: MicroRNA-381 represses ID1 and is deregulated in lung adenocarcinoma. J Thorac Oncol 2012;7:1069-1077.
22. Tang H, Liu X, Wang Z, She X, Zeng X, Deng M, Liao Q, Guo X, Wang R, Li X, Zeng F, Wu M, Li G: Interaction of hsa-miR-381 and glioma suppressor LRRC4 is involved in glioma growth. Brain Res 2011;1390:21-32.
23. Hu Z, Shu Y, Chen Y, Chen J, Dong J, Liu Y, Pan S, Xu L, Xu J, Wang Y, Dai J, Ma H, Jin G, Shen H: Genetic polymorphisms in the precursor MicroRNA flanking region and non-small cell lung cancer survival. Am J Respir Crit Care Med 2011;,183:641-648.
24. Thirion S, Berenbaum F: Culture and phenotyping of chondrocytes in primary culture. Methods Mol Med 2004;100:1-14.
25. Newton PT, Staines KA, Spevak L, Boskey AL, Teixeira CC, Macrae VE, Canfield AE, Farquharson C: Chondrogenic ATDC5 cells: An optimised model for rapid and physiological matrix mineralisation. Int J Mol Med 2012;30:1187-1193.
26. Liu X, Liu J, Kang N, Yan L, Wang Q, Fu X, Zhang Y, Xiao R, Cao Y: Role of insulin-transferrin-selenium in auricular chondrocyte proliferation and engineered cartilage formation in vitro. Int J Mol Sci 2014;15:1525-1537.
27. Zhang L, Song H, Zhao X: Optimum combination of insulin-transferrin-selenium and fetal bovine serum for culture of rabbit articular chondrocytes in three-dimensional alginate scaffolds. Int J Cell Biol 2009;2009:747016.
28. Yao Y, Wang Y: ATDC5: An excellent in vitro model cell line for skeletal development. J Cell Biochem 2013;114:1223-1229.
29. Atsumi T, Miwa Y, Kimata K, Ikawa Y: A chondrogenic cell line derived from a differentiating culture of AT805 teratocarcinoma cells. Cell Differ Dev 1990;30:109-116.
30. Miyaki S, Nakasa T, Otsuki S, Grogan SP, Higashiyama R, Inoue A, Kato Y, Sato T, Lotz MK, Asahara H: MicroRNA-140 is expressed in differentiated human articular chondrocytes and modulates interleukin-1 responses. Arthritis Rheum 2009;60:2723-2730.
31. Simsa-Maziel S, Monsonego-Ornan E: Interleukin-1beta promotes proliferation and inhibits differentiation of chondrocytes through a mechanism involving down-regulation of FGFR-3 and p21. Endocrinology 2012;153:2296-2310.
32. MacRae VE, Farquharson C, Ahmed SF: The restricted potential for recovery of growth plate chondrogenesis and longitudinal bone growth following exposure to pro-inflammatory cytokines. J Endocrinol 2006;189:319-328.
33. Chen-An P, Andreassen KV, Henriksen K, Karsdal MA, Bay-Jensen AC: Investigation of chondrocyte hypertrophy and cartilage calcification in a full-depth articular cartilage explants model. Rheumatol Int 2013;33:401-411.
34. Pullig O, Weseloh G, Ronneberger D, Käkönen S, Swoboda B: Chondrocyte differentiation in human osteoarthritis: expression of osteocalcin in normal and osteoarthritic cartilage and bone. Calcif Tissue Int 2000;67:230-240.
35. Girkontaite I, Frischholz S, Lammi P, Wagner K, Swoboda B, Aigner T, Von der Mark K: Immunolocalization of type X collagen in normal fetal and adult osteoarthritic cartilage with monoclonal antibodies. Matrix Biol 1996;15:231-238.
36. Goldring MB, Otero M, Tsuchimochi K, Ijiri K, Li Y: Defining the roles of inflammatory and anabolic cytokines in cartilage metabolism. Ann Rheum Dis 2008;67:S iii75-82.
37. Marcu KB, Otero M, Olivotto E, Borzi RM, Goldring MB: NF-kappaB signaling: multiple angles to target OA. Curr Drug Targets 2010;11:599-613.
38. Okamoto H, Cujec TP, Yamanaka H, Kamatani N: Molecular aspects of rheumatoid arthritis: role of transcription factors. FEBS J 2008;275:4463-4470.
39. Goldring MB, Otero M, Plumb DA, Dragomir C, Favero M, El Hachem K, Hashimoto K, Roach HI, Olivotto E, Borzi RM, Marcu KB: Roles of Inflammatory and anabolic cytokines in cartilage metabolism: signals and multiple effectors converge upon MMP-13 regulation in osteoarthritis. Eur Cell Mater 2011;21:202-220.
40. Kawai J, Akiyama H, Shigeno C, Ito H, Konishi J, Nakamura T: Effects of transforming growth factor-beta signaling on chondrogenesis in mouse chondrogenic EC cells, ATDC5. Eur J Cell Biol 1999;78:707-714.
41. Sonomoto K, Yamaoka K, Oshita K, Fukuyo S, Zhang X, Nakano K, Okada Y, Tanaka Y: Interleukin-1beta induces differentiation of human mesenchymal stem cells into osteoblasts via the Wnt-5a/receptor tyrosine kinase-like orphan receptor 2 pathway. Arthritis Rheum 2012;64:3355-3363.
42. Han F, Gilbert JR, Harrison G, Adams CS, Freeman T, Tao Z, Zaka R, Liang H,Williams C, Tuan RS, Norton PA, Hickok NJ: Transforming growth factor-beta1 regulates fibronectin isoform expression and splicing factor SRp40 expression during ATDC5 chondrogenic maturation. Exp Cell Res 2007;313:1518-1532.
43. Oca P, Zaka R, Dion AS, Freeman TA, Williams CJ: Phosphate and calcium are required for TGFbeta-mediated stimulation of ANK expression and function during chondrogenesis. J Cell Physiol 2010;224:540-548.
44. El-Hoss J, Kolind M, Jackson MT, Deo N, Mikulec K, McDonald MM, Little CB, Little DG, Schindeler A: Modulation of endochondral ossification by MEK inhibitors PD0325901 and AZD6244 (Selumetinib). Bone 2014;59:151-161.
45. Wang X, Manner PA, Horner A, Shum L, Tuan RS, Nuckolls GH: Regulation of MMP-13 expression by RUNX2 and FGF2 in osteoarthritic cartilage. Osteoarthritis Cartilage 2004;12:963-973.
46. Chen CG, Thuillier D, Chin EN, Alliston T: Chondrocyte-intrinsic Smad3 represses Runx2-inducible matrix metalloproteinase 13 expression to maintain articular cartilage and prevent osteoarthritis. Arthritis Rheum 2012;64:3278-3289.
47. Qing YF, Zhang QB, Zhou JG, Jiang L: Changes in toll-like receptor (TLR)4-NFkappaB-IL1beta signaling in male gout patients might be involved in the pathogenesis of primary gouty arthritis. Rheumatol Int 2014;34:213-220.
48. Lee AS, Ellman MB, Yan D, Kroin JS, Cole BJ, van Wijnen AJ, Im HJ: A current review of molecular mechanisms regarding osteoarthritis and pain. Gene 2013;527:440-447.
49. Akhtar N, Rasheed Z, Ramamurthy S, Anbazhagan AN, Voss FR, Haqqi TM: MicroRNA-27b regulates the expression of matrix metalloproteinase 13 in human osteoarthritis chondrocytes. Arthritis Rheum 2010;62:1361-1371.
50. Yamasaki K, Nakasa T, Miyaki S, Ishikawa M, Deie M, Adachi N, Yasunaga Y, Asahara H, Ochi M: Expression of MicroRNA-146a in osteoarthritis cartilage. Arthritis Rheum2009;60:1035-1041.
51. Tardif G, Hum D, Pelletier JP, Duval N, Martel-Pelletier J: Regulation of the IGFBP-5 and MMP-13 genes by the microRNAs miR-140 and miR-27a in human osteoarthritic chondrocytes. BMC Musculoskelet Disord 2009;10:148.
52. Jones SW, Watkins G, Le Good N, Roberts S, Murphy CL, Brockbank SM, Needham MR, Read SJ, Newham P: The identification of differentially expressed microRNA in osteoarthritic tissue that modulate the production of TNF-alpha and MMP13. Osteoarthritis Cartilage 2009;17:464-472.
53. Vincenti MP, Brinckerhoff CE: Transcriptional regulation of collagenase (MMP-1, MMP-13) genes in arthritis: integration of complex signaling pathways for the recruitment of gene-specific transcription factors. Arthritis Res 2002;4:157-164.
54. Iliopoulos D, Malizos KN, Oikonomou P, Tsezou A: Integrative microRNA and proteomic approaches identify novel osteoarthritis genes and their collaborative metabolic and inflammatory networks. PLoS One 2008;3:e3740.
55. Reiter LA, Freeman-Cook KD, Jones CS, Martinelli GJ, Antipas AS, Berliner MA, Datta K, Downs JT, Eskra JD, Forman MD, Greer EM, Guzman R, Hardink JR, Janat F, Keene NF, Laird ER, Liras JL, Lopresti-Morrow LL, Mitchell PG, Pandit J, Robertson D, Sperger D, Vaughn-Bowser ML, Waller DM, Yocum SA: Potent, selective pyrimidinetrione-based inhibitors of MMP-13. Bioorg Med Chem Lett 2006;16:5822-5826.
56. Latronico MVG and Condorelli G: Therapeutic use of MicroRNAs in Myocardial Disease. Curr Heart Fail Rep 2011;8:193-197.
57. Kolfschoten IGM, Rogglit E, Nesca V, Regazzi R: Role and Therapeutic Potential of microRNAs in Diabetes. Diabetes Obes Metab 2009;11:S118-129.
58. Yeung ML and Jeang KT: MicroRNAs and Cancer Therapeutics. Pharm Res 2011;28:3043-3049.
59. Kanwal N, John P, Bhatti A: MicroRNA-155 as a therapeutic target for inflammatory diseases. Rheumatol Int 2013;33:557-560.